Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5926 AL 5940

Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a β regression meta-analysis

Rogers JA, Polhamus D, Gillespie WR, Ito K, Romero K, Qiu R, Stephenson D, Gastonguay MR, Corrigan B.

J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):479-98. doi: 10.1007/s10928-012-9263-3. Epub 2012 Jul 21.

The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention

Giunta B, Obregon D, Velisetty R, Sanberg PR, Borlongan CV, Tan J.

J Neuroinflammation. 2012 Aug 1;9:185. doi: 10.1186/1742-2094-9-185.

Antioxidant therapies for Alzheimer's disease

Feng Y, Wang X.

Oxid Med Cell Longev. 2012;2012:472932. doi: 10.1155/2012/472932. Epub 2012 Jul 25.

Association between chronic blood pressure changes and development of Alzheimer's disease

Feldstein CA.

J Alzheimers Dis. 2012;32(3):753-63. doi: 10.3233/JAD-2012-120613.

What are the prospects of slowing the progression of Alzheimer's disease?

Palmer AM.

Drug Discov Today. 2012 Nov;17(21-22):1157-9. doi: 10.1016/j.drudis.2012.09.009. Epub 2012 Oct 2.

Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes

Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova C.

Drugs Aging. 2012 Oct;29(10):793-806. doi: 10.1007/s40266-012-0012-5.

Estrogens and Alzheimer disease risk: is there a window of opportunity?

Henderson VW, Rocca WA.

Neurology. 2012 Oct 30;79(18):1840-1. doi: 10.1212/WNL.0b013e318271f88f. Epub 2012 Oct 24.

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression

Rountree SD, Atri A, Lopez OL, Doody RS.

Alzheimers Dement. 2013 May;9(3):338-45. doi: 10.1016/j.jalz.2012.01.002. Epub 2012 Oct 24.

Angiotensin-receptor blockers, hypertension and Alzheimer disease--the entangled relationship

Katayama T, Hasebe N.

Circ J. 2013;77(2):315-6. doi: 10.1253/circj.cj-12-1550. Epub 2012 Dec 22.

Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study

Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):113-8. doi: 10.1097/WAD.0b013e3182222bc0.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial

Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.

J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217.

Auditory delta event-related oscillatory responses are decreased in Alzheimer's disease

Yener GG, Güntekin B, Örken DN, Tülay E, Forta H, Başar E.

Behav Neurol. 2012;25(1):3-11. doi: 10.3233/BEN-2012-0344.

Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

Svedberg MM, Rahman O, Hall H.

Nucl Med Biol. 2012 May;39(4):484-501. doi: 10.1016/j.nucmedbio.2011.10.007. Epub 2012 Jan 5.

Peptides for therapy and diagnosis of Alzheimer's disease

Funke SA, Willbold D.

Curr Pharm Des. 2012;18(6):755-67. doi: 10.2174/138161212799277752.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias